Only the right has signed this so far (Bill Ranking)
H.R. 1060 · 119th Congress (2025-2026)
4 members · Left 0 · Center 2 · Right 2 (Bill Ranking)
| Sponsor | Rep. Davis, Donald G. (D-NC) (Introduced 02/06/2025) |
|---|---|
| Sponsor Voting Record | Center · DW-NOMINATE -0.24 · measured from every roll-call vote this member has cast (voteview.com) (Sponsor Ranking) |
| Support |
LLLCLRR support across the spectrum: 4 members signed on (Bill Ranking) this bill: sponsor + current cosponsors, each once |
| Committees | House - Energy and Commerce Committee |
| Latest Action | 02/06/2025 Referred to the House Committee on Energy and Commerce. |
| Roll Call Votes | There have been no roll call votes |
| Source | view on congress.gov → |
Introduced in House (02/06/2025)
Modern Authentication of Pharmaceuticals Act of 2025
This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.
The bill applies to products manufactured beginning five years after the bill's enactment.
119 HR 1060 IH: Modern Authentication of Pharmaceuticals Act of 2025 U.S. House of Representatives 2025-02-06 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I119th CONGRESS1st SessionH. R. 1060IN THE HOUSE OF REPRESENTATIVESFebruary 6, 2025Mr. Davis of North Carolina (for himself, Mr. Rutherford, and Mr. Bacon) introduced the following bill; which was referred to the Committee on Energy and CommerceA BILLTo amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.1.Short titleThis Act may be cited as the Modern Authentication of Pharmaceuticals Act of 2025.2.Modernizing the authentication of controlled substances in the pharmaceutical distribution supply chain(a)In generalSection 582(a)(9) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee–1(a)(9)) is amended—(1)in subparagraph (A)(ii), by striking and at the end;(2)by redesignating subparagraph (B) as subparagraph (C); and(3)by inserting after subparagraph (A) the following:(B)a physical chemical identifier shall be included in or on each dose of a product that is—(i)a controlled substance (as defined in section 102 of the Controlled Substances Act);(ii)in solid oral dosage form; and(iii)manufactured on or after the date that is five years after the date of enactment of the Modern Authentication of Pharmaceuticals Act of 2025; and.(b)Conforming changes(1)Section 581(14) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(14)) is amended to read as follows:(14)Product identifierThe term product identifier means—(A)a standardized graphic that includes, in both human-readable form and on a machine-readable data carrier that conforms to the standards developed by a widely recognized international standards development organization, the standardized numerical identifier, lot number, and expiration date of the product; or(B)a physical chemical identifier, possessing a unique physical or chemical substance or combination of substances, that—(i)is in or on a product;(ii)is machine readable; and(iii)is intended to authenticate the product or a dosage form thereof..(2)Section 581(28) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360eee(28)) is amended to read as follows:(28)Verification or verifyThe term verification or verify means—(A)determining whether the product identifier affixed to, or imprinted upon, a package or homogeneous case corresponds to the standardized numerical identifier or lot number and expiration date assigned to the product by the manufacturer or the repackager, as applicable in accordance with section 582; or(B)determining whether a product or a dosage form thereof is authentic using a physical chemical identifier described in paragraph (14)(B)..
The bill's own words, from our database (synced from the GPO BILLS XML); paragraph breaks added at the bill's section boundaries, nothing else changed.
| Date | Chamber | All Actions |
|---|---|---|
| 02/06/2025 | Library of Congress | Introduced in House |
| 02/06/2025 | Library of Congress | Sponsor introductory remarks on measure. (CR H519) |
| 02/06/2025 | Library of Congress | Introduced in House |
| 02/06/2025 | House floor actions | Referred to the House Committee on Energy and Commerce. |
| Title Type | Title |
|---|---|
| Display Title | Modern Authentication of Pharmaceuticals Act of 2025 |
| Short Title(s) as Introduced | Modern Authentication of Pharmaceuticals Act of 2025 |
| Official Title as Introduced | To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes. |
There are no amendments to this bill.
* = Original cosponsor
| Committee | Activity |
|---|---|
| House - Energy and Commerce Committee | 02/06/2025 Referred To |
No related bill information was received for H.R. 1060.
Policy Area: Health
All data on this page comes from our own database (legislation.congress_* tables), synced daily from the GPO govinfo BILLSTATUS and BILLS collections. Formatted after congress.gov; nothing is generated. Member placement is their DW-NOMINATE score (voteview.com, Lewis et al.) - a measurement of roll-call voting behavior, not our judgement. Buckets: Left below −0.50 · Lean Left to −0.25 · Center to +0.25 · Lean Right to +0.50 · Right above +0.50. The bill's Support meter aggregates the people who signed the bill - sponsor and current cosponsors, each counted once - nothing else.